Orchestra BioMed Holdings, Inc. Cash and Restricted Cash
Orchestra BioMed Holdings, Inc. (OBIO) had Cash and Restricted Cash of $20.47 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $20.47M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28.37M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $34.69M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $42.01M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $20.47M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $28.37M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $34.69M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $42.01M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $18.75M 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $18.35M 10-Q · filed 2026-05-12 | |
| 2024-12-31 | $22.26M 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $25.61M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $23.71M 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $23.32M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $30.56M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $19.08M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $16.41M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $18.70M 10-Q · filed 2024-05-13 | |
| 2022-12-31 | $19.78M 10-K · filed 2025-03-31 | $175.16K 10-K · filed 2023-01-25 |
| 2022-09-30 | $97.00M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $106.97M 10-Q · filed 2023-08-10 | $1.31M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $29.33M 10-Q · filed 2023-05-12 | $1.42M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $9.94M 10-K · filed 2024-03-27 | $1.75M 10-Q · filed 2022-05-13 |
| 2021-06-30 | $1.91M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $1.95M 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $2.03M 10-K · filed 2023-01-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |